The estimated Net Worth of Marc G Naughton is at least $70.2 Milion dollars as of 29 April 2020. Mr Naughton owns over 6,968 units of Cerner stock worth over $8,768,227 and over the last 22 years he sold CERN stock worth over $60,145,575. In addition, he makes $1,327,322 as Exec. Advisor at Cerner.
Mr has made over 25 trades of the Cerner stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 6,968 units of CERN stock worth $661,681 on 29 April 2020.
The largest trade he's ever made was selling 176,000 units of Cerner stock on 6 February 2020 worth over $13,930,400. On average, Mr trades about 16,337 units every 108 days since 2003. As of 29 April 2020 he still owns at least 92,336 units of Cerner stock.
You can see the complete history of Mr Naughton stock trades at the bottom of the page.
Marc G. Naughton is the Exec. Advisor at Cerner.
As the Exec. Advisor of Cerner, the total compensation of Mr Naughton at Cerner is $1,327,322. There are 2 executives at Cerner getting paid more, with David Brent Shafer having the highest compensation of $2,321,204.
Mr Naughton is 66, he's been the Exec. Advisor of Cerner since . There are no older and 7 younger executives at Cerner.
Marc's mailing address filed with the SEC is 2800 ROCKCREEK PARKWAY, , NORTH KANSAS CITY, MO, 64117.
Over the last 22 years, insiders at Cerner have traded over $915,181,313 worth of Cerner stock and bought 84,702 units worth $5,189,349 . The most active insiders traders include Neal L Patterson, Clifford W Illig oraz Jeffrey A Townsend. On average, Cerner executives and independent directors trade stock every 12 days with the average trade being worth of $3,365,003. The most recent stock trade was executed by Michael R. Battaglioli on 4 May 2022, trading 5,288 units of CERN stock currently worth $497,548.
Cerner's health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people.
Cerner executives and other stock owners filed with the SEC include: